Verification evidence is still being completed.
Evotec
Hamburg, Germany
- Verified lead
- Dr. Christian Wojczewski
- Lead status
- STATUS: VERIFIED MARCH 2026
- Leadership verification
- Chief Executive Officer and Chair of the Management Board
- 2026 technical specialization
- Drug Discovery and Platform Development
- Review cycle
- May 2026
- Full address
- Manfred Eigen Campus, Essener Bogen 7, 22419 Hamburg, Germany
- Site coordinates
- Verification evidence is still being completed.
- Editorial review
- Memel Biotech editorial review
- Official leadership source
- Official Evotec management board page confirming Dr. Christian Wojczewski as CEO.
- Editorial note
- Evotec remains a verified German discovery-and-platform anchor with explicit cluster linkage to major therapeutic and industrial partners.
Drug Discovery and Platform Development
Integrated R&D Platform, Industrial Biotech Partnerships
Evotec remains a verified German discovery-and-platform anchor with explicit cluster linkage to major therapeutic and industrial partners.
Evotec remains a verified German discovery-and-platform anchor with explicit cluster linkage to major therapeutic and industrial partners.
- Lead
- Dr. Christian Wojczewski (verified ↗)
- Address
- Manfred Eigen Campus, Essener Bogen 7, 22419 Hamburg, Germany (source ↗)
- Compliance
- GLP
- Last reviewed
- 14 Mar 2026 (3mo ago)
- Scale
- Global research platform
- Capabilities
- Integrated Drug Discovery · Translational Biology · Biologics and Platform Partnerships
- Founded
- 1993
- Headcount
- 1001-5000
- Company page (open ↗)
Dr. Christian Wojczewski
Chief Executive Officer and Chair of the Management Board
Official Evotec worldwide locations page naming the Manfred Eigen Campus at Essener Bogen 7 in Hamburg.
Open sourceGlobal research platform
Hamburg, Germany. Drug Discovery and Platform Development. Review completed on 14 Mar 2026.
German and EU biopharma research oversight
Integrated R&D Platform, Industrial Biotech Partnerships
Drug Discovery and Platform Development
Evotec remains a verified German discovery-and-platform anchor with explicit cluster linkage to major therapeutic and industrial partners.
Evotec remains a verified German discovery-and-platform anchor with explicit cluster linkage to major therapeutic and industrial partners.
Core capabilities
Primary declared technical activities and areas of operating focus.
Verification source dossier
Official source set used to support leadership, physical-site, certification, and watch-note evidence.
Declared infrastructure
Quality system coverage
GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.
- GMP
- REVIEW IN PROGRESS 2026
- GLP
- VERIFIED ACTIVE 2026
- ISO-13485
- REVIEW IN PROGRESS 2026
- FDA-Inspected
- REVIEW IN PROGRESS 2026
Verification history
Frequently asked questions
- Where is Evotec located?
- Evotec operates from Manfred Eigen Campus, Essener Bogen 7, 22419 Hamburg, Germany, Hamburg, Germany.
- Who runs Evotec?
- Evotec is led by Dr. Christian Wojczewski, Chief Executive Officer and Chair of the Management Board. Verified 14 Mar 2026.
- What does Evotec do?
- Evotec remains a verified German discovery-and-platform anchor with explicit cluster linkage to major therapeutic and industrial partners. Core capabilities: Integrated Drug Discovery, Translational Biology, Biologics and Platform Partnerships.
Related technical briefs
Briefs that name Hamburg as a covered market or city.
